CR10934A - Nuevo procedimiento de sintesis de la agomelatina - Google Patents

Nuevo procedimiento de sintesis de la agomelatina

Info

Publication number
CR10934A
CR10934A CR10934A CR10934A CR10934A CR 10934 A CR10934 A CR 10934A CR 10934 A CR10934 A CR 10934A CR 10934 A CR10934 A CR 10934A CR 10934 A CR10934 A CR 10934A
Authority
CR
Costa Rica
Prior art keywords
synthesis procedure
new
agomelatine synthesis
new agomelatine
procedure
Prior art date
Application number
CR10934A
Other languages
English (en)
Inventor
Hardouin Christophe
Lecouve Jean-Pierre
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of CR10934A publication Critical patent/CR10934A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/08—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Transplantation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)

Abstract

Procedimiento de sintesis industrial del compuesto de formula (I).
CR10934A 2008-08-05 2009-07-16 Nuevo procedimiento de sintesis de la agomelatina CR10934A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0804464A FR2934855B1 (fr) 2008-08-05 2008-08-05 Nouveau procede de synthese de l'agomelatine

Publications (1)

Publication Number Publication Date
CR10934A true CR10934A (es) 2009-10-15

Family

ID=40409856

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10934A CR10934A (es) 2008-08-05 2009-07-16 Nuevo procedimiento de sintesis de la agomelatina

Country Status (46)

Country Link
US (1) US8143449B2 (es)
EP (1) EP2151429B1 (es)
JP (1) JP5021004B2 (es)
KR (1) KR101127357B1 (es)
CN (1) CN101643431B (es)
AP (1) AP2509A (es)
AR (1) AR074887A1 (es)
AT (1) ATE510816T1 (es)
AU (1) AU2009202905B2 (es)
BR (1) BRPI0903045A2 (es)
CA (1) CA2674764C (es)
CL (1) CL2009001632A1 (es)
CR (1) CR10934A (es)
CU (1) CU23858B1 (es)
CY (1) CY1111573T1 (es)
DK (1) DK2151429T3 (es)
EA (1) EA017684B1 (es)
EC (1) ECSP099549A (es)
ES (1) ES2367236T3 (es)
FR (1) FR2934855B1 (es)
GE (1) GEP20115344B (es)
GT (1) GT200900218A (es)
HK (1) HK1141004A1 (es)
HN (1) HN2009001435A (es)
HR (1) HRP20110568T1 (es)
IL (1) IL199875A (es)
JO (1) JO2821B1 (es)
MA (1) MA31830B1 (es)
ME (1) ME00927B (es)
MX (1) MX2009007971A (es)
MY (1) MY144746A (es)
NI (1) NI200900152A (es)
NZ (1) NZ578381A (es)
PE (1) PE20100259A1 (es)
PL (1) PL2151429T3 (es)
PT (1) PT2151429E (es)
RS (1) RS51740B (es)
SA (1) SA109300498B1 (es)
SG (1) SG158814A1 (es)
SI (1) SI2151429T1 (es)
SV (1) SV2009003344A (es)
TW (1) TWI376365B (es)
UA (1) UA106195C2 (es)
UY (1) UY31985A (es)
WO (1) WO2010015746A1 (es)
ZA (1) ZA200905051B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011154140A2 (en) 2010-06-10 2011-12-15 Gador S.A. New process for the preparation of n-[2-(7-methoxy-1-naphthyl)-ethyl]acetamide and new crystalline form
CN102531956B (zh) * 2010-12-21 2014-07-09 浙江九洲药业股份有限公司 用于制备阿戈美拉汀的中间体及相关制备方法
US8561395B2 (en) 2011-03-03 2013-10-22 Tenneco Automotive Operating Company Inc. Poka-yoke mounting system for an exhaust treatment device
EP2562151A1 (en) * 2011-08-25 2013-02-27 Dr. Reddy's Laboratories Ltd. Processes for the preparation of agomelatine and its intermediates
ITMI20121444A1 (it) 2012-08-27 2014-02-28 Procos Spa Processo per la produzione di agomelatine
FR3014437B1 (fr) * 2013-12-05 2016-12-23 Servier Lab Nouveau procede de synthese de l'agomelatine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO1996007635A1 (fr) * 1994-09-06 1996-03-14 Shionogi & Co., Ltd. Procede de production de derive d'alcoxyiminoacetamide
FR2734816B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine

Also Published As

Publication number Publication date
JP2010043078A (ja) 2010-02-25
FR2934855A1 (fr) 2010-02-12
CU23858B1 (es) 2013-02-26
AP2009004929A0 (en) 2009-08-31
EA017684B1 (ru) 2013-02-28
NZ578381A (en) 2010-11-26
SI2151429T1 (sl) 2011-09-30
GT200900218A (es) 2010-08-23
ECSP099549A (es) 2010-03-31
KR101127357B1 (ko) 2012-04-12
HRP20110568T1 (en) 2011-09-30
CN101643431B (zh) 2013-05-15
EA200900943A1 (ru) 2010-04-30
UY31985A (es) 2010-01-29
MA31830B1 (fr) 2010-11-01
PL2151429T3 (pl) 2011-11-30
CU20090131A7 (es) 2011-05-27
ATE510816T1 (de) 2011-06-15
SA109300498B1 (ar) 2013-07-23
PE20100259A1 (es) 2010-04-10
CN101643431A (zh) 2010-02-10
DK2151429T3 (da) 2011-09-19
SG158814A1 (en) 2010-02-26
AR074887A1 (es) 2011-02-23
CA2674764A1 (fr) 2010-02-05
IL199875A0 (en) 2010-05-17
UA106195C2 (ru) 2014-08-11
US20100036163A1 (en) 2010-02-11
KR20100017060A (ko) 2010-02-16
CA2674764C (fr) 2012-04-17
WO2010015746A1 (fr) 2010-02-11
CY1111573T1 (el) 2015-10-07
ES2367236T3 (es) 2011-10-31
ME00927B (me) 2012-06-20
PT2151429E (pt) 2011-07-11
RS51740B (en) 2011-10-31
HN2009001435A (es) 2011-12-27
EP2151429A1 (fr) 2010-02-10
JP5021004B2 (ja) 2012-09-05
BRPI0903045A2 (pt) 2010-05-25
ZA200905051B (en) 2010-05-26
MY144746A (en) 2011-10-31
SV2009003344A (es) 2010-02-05
TW201018658A (en) 2010-05-16
EP2151429B1 (fr) 2011-05-25
CL2009001632A1 (es) 2010-07-19
MX2009007971A (es) 2010-03-25
AP2509A (en) 2012-11-19
AU2009202905B2 (en) 2013-09-05
AU2009202905A1 (en) 2010-02-25
TWI376365B (en) 2012-11-11
JO2821B1 (en) 2014-09-15
US8143449B2 (en) 2012-03-27
NI200900152A (es) 2010-03-25
GEP20115344B (en) 2011-12-12
FR2934855B1 (fr) 2010-08-13
HK1141004A1 (en) 2010-10-29
IL199875A (en) 2013-10-31

Similar Documents

Publication Publication Date Title
CR10955A (es) Nuevo procedimiento de sintesis de la agomelatina
CR10960A (es) Nuevo procedimiento de sintesis de la agomelatina
CR20120295A (es) Triazolopiridinas
CR20120297A (es) Espironucleósidos uracílicos oxetánicos
UY31229A1 (es) Nuevo procedimiento de sintesis del (7-metoxi-1-naftil)acetonitrilo y aplicacion a la sintesis de la agomelatina
EA201101099A1 (ru) Гербициды, полученные из циклопентадиона
PA8797001A1 (es) Nuevo procedimiento de sintesis del ranelato de estroncio y de sus hidratos
EA201101675A1 (ru) Спироэпоксиды как промежуточные продукты синтеза
CR10934A (es) Nuevo procedimiento de sintesis de la agomelatina
CR10952A (es) Nuevo procedimiento de obtencion de la forma cristalina v de la agomelatina
ECSP13012735A (es) Nuevo procedimiento de síntesis de la agomelatina
CU20130087A7 (es) Nuevo procedimiento de síntesis de la agomelatina
CU20080181A7 (es) Nuevo procedimiento de síntesis del ranelato de estroncio y de sus hidratos